VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA.
Company Fireside Chat Presentation Details: | |
Date: | Monday, June 12, 2023 |
Time: | 10:00 am Pacific Time (1:00 pm Eastern Time) |
Webcast: | Register here |
Presenters: |
Ian Mortimer, President and CEO
Sherry Aulin, CFO |
A live webcast of the company presentation will be available on the “
Investors
” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com .
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Investor/Media Contact
:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email:
investors@xenon-pharma.com